Brief: Evolent Health Outlook Q2 Adjusted EBITDA USD 33-40 Million
20/06/2025 11:30
Jun 20 (Reuters) - Evolent Health outlook FY adjusted EBITDA USD 135-165 million.
Recent news on Evolent Health
See all newsEvolent Health, Inc. reports results for the quarter ended June 30 - Earnings Summary
Evolent Health Q2 revenue beats expectations
Brief: Evolent Health Q2 Revenue USD 652.52 Million Vs. IBES Estimate USD 598 Million
Evolent Health, Inc. expected to post a loss of 2 cents a share - Earnings Preview
Evolent Health Q1 revenue misses estimates as margin narrows